Moxonidine Viatris

Moxonidine, the active ingredient in Moxonidine Viatris, is an imidazoline receptor agonist presented as an oral tablet for oral use. It selectively stimulates central imidazoline I1 receptors, reducing sympathetic nervous system activity and thereby lowering elevated blood pressure in adult patients with hypertension.

GNH USA supplies Moxonidine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing and reliable distribution across global markets.

Moxonidine is an antihypertensive agent that acts on central imidazoline receptors to manage high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension. - Resistant hypertension: provides additional blood pressure reduction when other antihypertensive agents are insufficient.

Moxonidine may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially on standing. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzyme elevations. - Cardiac arrhythmia: irregular heart rhythm. - Syncope: sudden loss of consciousness.

When prescribing Moxonidine, clinicians should consider several precautionary measures to ensure safe use.

- Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Elderly patients: start with lower dose and monitor for dizziness. - Discontinuation: avoid abrupt cessation to prevent rebound hypertension. - Store at room temperature: keep in original container, protect from moisture and heat.

Moxonidine can interact with other medicines, requiring attention to avoid clinically significant effects.

Major Interactions (Avoid): - Concomitant use with other central antihypertensives (e.g., clonidine) may cause severe hypotension. - Combination with potent vasodilators (e.g., nitroprusside) can lead to additive blood pressure lowering.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) may attenuate the antihypertensive effect. - Diuretics may increase risk of electrolyte imbalance and orthostatic hypotension. - Beta‑blockers may mask tachycardia symptoms.